Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Länsförsäkringar Skåne’s real estate company Länshem Skåne in connection with an acquisition from Skanska
Mandate

Vinge has advised Länsförsäkringar Skåne’s real estate company Länshem Skåne in connection with an acquisition from Skanska

August 23, 2019

Vinge has advised Länsförsäkringar Skåne’s real estate company Länshem Skåne AB in connection with the acquisition from Skanska of two property companies and thereby indirectly two commercial properties with a total of 109 apartments in Helsingborg.

Vinge’s team consisted of Henrik Ossborn together with, among others, associates Fredrik Christiansson, Jessica Salomonsson and Jack Bengtsson. Mathias Lindquist advised on the environmental issues and Maria Schutzberg provided tax law advice. 

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026